Compliance Management White Papers & Case Studies

1. Evaluation Of Novel Process Indicators For Hydrogen Peroxide Decontamination 6/30/2026

   Immediate, quantifiable verification replaces seven-day incubation periods. Discover how enzyme-based indicators optimize hydrogen peroxide decontamination.

2. Developing A Method To Assess Product And Personnel Safety In vH2O2 Decontamination Cycles 6/30/2026

   Discover how ultra-sensitive spectroscopy transforms decontamination validation, revealing hidden efficiencies that safely cut facility downtime while ensuring absolute safety.

3. Engineering The Future Of Antibody-Drug Conjugates 6/26/2026

   As ADCs expand into broader use, upstream process design is becoming a competitive advantage. Discover how smarter media strategies and data-driven decision-making are helping teams reduce risk.

4. Delivering Critical Therapies With Speed And Safety 6/26/2026

   Faster approvals depend on treating regulation as part of development, not the finish line. See how early quality planning and strong agency communication can move therapies toward patients sooner.

5. Context-First Data For Trustworthy AI In Biopharma 6/26/2026

   Bridge the gap between AI experimentation and enterprise value. Learn how capturing structured, semantically rich data at the point of origin builds regulator-credible AI pipelines.

6. Top Questions Before You Buy A Hazardous Pharmacy Compounding Isolator 6/25/2026

   Move beyond brochure specifications for hazardous compounding. Learn the critical airflow, structural, and pressure requirements needed to ensure long-term facility safety.

7. Where Speed Meets Complexity In Bioprocess Development 6/18/2026

   Bioprocessing faces mounting pressure to compress timelines, especially for mAbs, while complex modalities like bispecifics and gene therapies introduce technical challenges. Process intensification, scale-up translation, and comparability risks remain critical hurdles.

8. Unlocking The Full Potential Of Antibody-Drug Conjugates (ADCs) 6/15/2026

   ADCs are evolving rapidly. Gain insight into how success now hinges on managing complexity, delivery, and scalability to turn promising designs into viable therapeutic products.

9. ADC Manufacturing: Practices, Challenges, And The Road Ahead 6/15/2026

   ADCs are advancing quickly, but manufacturing complexity is rising just as fast. Key challenges in scale-up, regulation, and costs are reshaping how the next generation of therapies will be delivered.

10. Leveraging Integrated Media Services For Speed And Efficiency 6/12/2026

    Uncertainty in media stability can limit efficiency and scalability in biologics manufacturing. See how a data-driven approach enables more predictable planning and reduces operational strain.